Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
MoonLake Immunotherapeutics
Biotech
MoonLake arthritis win kicks off pivotal year for IL-17 nanobody
MoonLake has kicked off a year of readouts for its much-hyped inflammatory disease prospect with a midstage win in a type of arthritis.
James Waldron
Feb 23, 2026 5:10am
MoonLake stock sinks as high placebo rate eclipses ph. 3 results
Sep 29, 2025 8:05am
Merck made $3B offer for MoonLake—and could revive interest: FT
Jun 3, 2025 9:25am
MoonLake and Komodo sign deal for health analytics tech
Apr 11, 2024 5:00am
MoonLake shines brighter as IL-17 drug scores latest phase 2 win
Nov 6, 2023 8:14am
MoonLake's IL-17 drug wins 'meet or beat' trial vs. competition
Jun 26, 2023 11:18am
